Rurality and Delayed Diagnosis of Giant Cell Arteritis-A Single-Center Experience
- PMID: 40768558
- PMCID: PMC12329242
- DOI: 10.1097/RHU.0000000000002267
Rurality and Delayed Diagnosis of Giant Cell Arteritis-A Single-Center Experience
Abstract
Objective: The study objectives were to compare the characteristics of patients with giant cell arteritis (GCA) from nonrural and rural areas and to identify factors associated with delayed GCA diagnosis.
Methods: In this historical cross-sectional analysis, adults meeting the 2022 European Alliance of Associations for Rheumatology/American College of Rheumatology GCA classification criteria and followed at the University of Iowa rheumatology clinics from 2/1/2000 to 2/7/2024 were included. Geographic categories were defined using the 2010 Rural-Urban Commuting Area (RUCA) codes. Characteristics of nonrural (RUCA 1-3) and rural (RUCA 4-10) GCA patient groups were compared. Bivariable analyses were performed between each predictor and time to GCA diagnosis with simple linear regression. Multivariable linear regression models were fitted to identify the best predictors of time to GCA diagnosis.
Results: In total, 317 subjects with GCA were included in this study (mean age, 72 years; 74.8% women). Nonrural (n = 172) and rural (n = 145) subjects had similar disease manifestations, including abrupt headache, vision loss, and jaw claudication. The mean time to GCA diagnosis was significantly longer in rural compared with nonrural GCA subjects (130 ± 185 vs. 45 ± 45 days, p < 0.0001). A significantly higher rate of hospitalizations was observed among rural subjects (24.1% vs. 12.2%, p = 0.0075). Bivariable analyses identified 4 variables associated with time to GCA diagnosis. In multivariable linear regression analyses, RUCA code (β = 13.99, 95% confidence interval, 9.23 to 18.75), age, and headache provided the best fit (adjusted R2 = 0.1196, Akaike corrected information criterion = 3082, p < 0.001).
Conclusion: Rurality was identified as the strongest predictor of delayed diagnosis in GCA. Rural patients also experienced delays in undergoing temporal artery biopsy and a higher proportion of hospitalizations.
Keywords: diagnosis; geographic disparities; giant cell arteritis.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Tocilizumab for giant cell arteritis.Cochrane Database Syst Rev. 2021 Aug 22;8(8):CD013484. doi: 10.1002/14651858.CD013484.pub2. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 13;5:CD013484. doi: 10.1002/14651858.CD013484.pub3. PMID: 34420204 Free PMC article. Updated.
-
Tocilizumab for giant cell arteritis.Cochrane Database Syst Rev. 2022 May 13;5(5):CD013484. doi: 10.1002/14651858.CD013484.pub3. Cochrane Database Syst Rev. 2022. PMID: 35560150 Free PMC article.
-
Aortic and Carotid Complications in Patients With Giant Cell Arteritis.Am J Ophthalmol. 2025 Jun 9;278:65-72. doi: 10.1016/j.ajo.2025.06.001. Online ahead of print. Am J Ophthalmol. 2025. PMID: 40499805
-
Investigation and analysis of mental health status of the older adult in western rural areas.Front Public Health. 2025 Jul 16;13:1612600. doi: 10.3389/fpubh.2025.1612600. eCollection 2025. Front Public Health. 2025. PMID: 40740371 Free PMC article.
-
Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis.Medicine (Baltimore). 2015 Apr;94(14):e622. doi: 10.1097/MD.0000000000000622. Medicine (Baltimore). 2015. PMID: 25860208 Free PMC article.
References
-
- Ponte C, Grayson PC, Robson JC, et al. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis 2022;81:1647–1653. - PubMed
-
- Untied States Census Population Projections.
-
- De Smit E, Palmer AJ, Hewitt AW. Projected worldwide disease burden from giant cell arteritis by 2050. J Rheumatol 2015;42:119–125. - PubMed
-
- Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatol Oxf Engl 2017;56:506–515. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources